Revisiting the role of hypoxia-inducible factors in pulmonary hypertension

Larissa Shimoda, Xin Yun, Gautam Sikka

Research output: Contribution to journalReview article


Pulmonary hypertension (PH) is a deadly condition with limited treatment options. Early studies implicated hypoxia-inducible factors (HIFs) as contributing to the development of hypoxia-induced PH. Recently, the use of cells derived from patients and transgenic animals with cell-specific deletions for various parts of the HIF system has furthered our understanding of the mechanisms by which HIFs control pulmonary vascular tone and remodeling to promote PH. Additionally, identification of HIF inhibitors further allows assessment of the potential for targeting HIFs to prevent and/or reverse PH. In this review, recent findings exploring the role of HIFs as potential mediators and therapeutic targets for PH are discussed.

Original languageEnglish (US)
Pages (from-to)33-40
Number of pages8
JournalCurrent Opinion in Physiology
StatePublished - Feb 1 2019

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Fingerprint Dive into the research topics of 'Revisiting the role of hypoxia-inducible factors in pulmonary hypertension'. Together they form a unique fingerprint.

  • Cite this